These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8878588)

  • 21. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic interactions of amikacin with selected β-lactams and fluoroquinolones against canine Escherichia coli isolates.
    Delis GA; Siarkou VI; Vingopoulou EI; Koutsoviti-Papadopoulou M; Batzias GC
    Res Vet Sci; 2018 Apr; 117():187-195. PubMed ID: 29291486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
    Isenberg HD; Alperstein P; France K
    Diagn Microbiol Infect Dis; 1999 Feb; 33(2):81-6. PubMed ID: 10091030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
    Mayer I; Nagy E
    APMIS; 2000 Apr; 108(4):261-6. PubMed ID: 10843412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA.
    Falla TJ; Chopra I
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3282-4. PubMed ID: 9835528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria.
    Bassetti M; Dembry LM; Farrel PA; Callan DA; Andriole VT
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):143-8. PubMed ID: 11750168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Importance of the antimicrobial mode of action of antibiotics for their combined effect with glycine in subinhibitory concentrations on microbial growth].
    Gillissen G; Schumacher M; Breuer-Werle M
    Pathol Biol (Paris); 1991 May; 39(5):451-4. PubMed ID: 1881674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial activity of gentamicin and ciprofloxacin against Gram-negative bacteria: interactions with pig and calf sera.
    Miglioli PA; Silini R; Carzeri O; Grabocka E; Allerberger F
    Pharmacol Res; 1999 Apr; 39(4):321-3. PubMed ID: 10208763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
    Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
    Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. l-Serine potentiates fluoroquinolone activity against Escherichia coli by enhancing endogenous reactive oxygen species production.
    Duan X; Huang X; Wang X; Yan S; Guo S; Abdalla AE; Huang C; Xie J
    J Antimicrob Chemother; 2016 Aug; 71(8):2192-9. PubMed ID: 27118777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT; Blondeau JM
    J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
    Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
    Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy and antagonism of combinations with quinolones.
    Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):255-61. PubMed ID: 1864285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Acinetobacter calcoaceticus to antimicrobial drugs, alone and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1989; 35(2):95-104. PubMed ID: 2758872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1986; 32(3):270-85. PubMed ID: 3086051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity.
    Ramadan MA; Tawfik AF; el-Kersh TA; Shibl AM
    J Infect Dis; 1995 Feb; 171(2):483-6. PubMed ID: 7844396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones.
    Tanaka G; Shigeta M; Komatsuzawa H; Sugai M; Suginaka H; Usui T
    Chemotherapy; 1999; 45(1):28-36. PubMed ID: 9876207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pancreatic tissue concentration of bactericidal antibiotics.
    Büchler M; Malfertheiner P; Friess H; Isenmann R; Vanek E; Grimm H; Schlegel P; Friess T; Beger HG
    Gastroenterology; 1992 Dec; 103(6):1902-8. PubMed ID: 1451983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.